Mealey's (December 4, 2020, 1:43 PM EST) -- NEW ORLEANS — The Fifth Circuit U.S. Court of Appeals on Dec. 2 affirmed the dismissal with prejudice of the claims of four women who claimed to have had permanent hair loss from the chemotherapy drug Taxotere, saying the plaintiffs repeatedly missed court deadlines to file plaintiff fact sheets (In Re: Taxotere Products Liability Litigation, No. 19-30631, 5th Cir., 2020 U.S. App. LEXIS 37667)....